4//SEC Filing
Davis Katherine Lyon 4
Accession 0001140361-19-008669
CIK 0001092662other
Filed
May 7, 8:00 PM ET
Accepted
May 8, 4:31 PM ET
Size
8.4 KB
Accession
0001140361-19-008669
Insider Transaction Report
Form 4
Davis Katherine Lyon
Director
Transactions
- Exercise/Conversion
Common Stock
2019-05-06$3.48/sh+46,875$163,125→ 112,943 total - Exercise/Conversion
Options to purchase
2019-05-06−46,875→ 0 totalExercise: $3.48Exp: 2019-06-19→ Common Stock (46,875 underlying) - Tax Payment
Common Stock
2019-05-06$7.15/sh−22,800$163,123→ 90,143 total
Footnotes (3)
- [F1]On May 6, 2019, the reporting person exercised previously issued options to purchase 46,875 shares of common stock of the Issuer.
- [F2]Represents the surrender of options to purchase shares of common stock to the Issuer to pay the exercise price for options exercised.
- [F3]The options vested and became exercisable as to 9,375 shares of common stock on June 19, 2014, the grant date, and the remaining 37,500 shares of common stock vested and became exercisable in four equal annual installments beginning on the first anniversary of the grant date.
Documents
Issuer
CHEMBIO DIAGNOSTICS, INC.
CIK 0001092662
Entity typeother
Related Parties
1- filerCIK 0001399265
Filing Metadata
- Form type
- 4
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 4:31 PM ET
- Size
- 8.4 KB